Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Clinithink
company
About
Clinithink offers cloud-based text processing capability to support data analytics, coding, and decision support in healthcare applications.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Analytics,Artificial Intelligence,Clinical Trials,Health Care,Information Services,Information Technology,Life Science,Software
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Clinithink, a London, UK-based healthcare software company. Led by CEO Chris Tackaberry, Clinithink has developed cloud-based text processing capability that can be used to support data analytics, coding and decision support in healthcare applications. Its patent-pending Clinical Language Indexing software (CLiX) uses Natural Language Processing (NLP) to construct coded output from physicians’ notes using industry data standards (ICD-9, ICD-10, and SNOMED CT).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Clinithink has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Mar 3, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 3, 2019 | Series B | — | 1 |
Merck
|
— | Detail |
| Apr 20, 2012 | Series A | — | 1 |
Vanguard Atlantic
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Clinithink is funded by 2 investors.
Merck
and Vanguard Atlantic
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Merck
|
Yes | Series B |
|
Vanguard Atlantic
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
